MedPath
HSA Approval

ALLERZAL F.C. TABLET 5MG

SIN14939P

ALLERZAL F.C. TABLET 5MG

ALLERZAL F.C. TABLET 5MG

February 4, 2016

MD PHARMACEUTICALS PTE. LTD.

MD PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMD PHARMACEUTICALS PTE. LTD.
Licence HolderMD PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

R06AE09

levocetirizine

Manufacturer Information

MD PHARMACEUTICALS PTE. LTD.

Standard Chem. & Pharm. Co., Ltd

Active Ingredients

Levocetirizine Dihydrochloride

5mg

Levocetirizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ALLERZAL F.C. TABLET 5MG - HSA Approval | MedPath